经尿道保留前列腺前叶等离子剜除术治疗前列腺增生症临床观察

Clinical Observation on Transurethral Plasmakinetic Enucleation of the Prostate in Treatment of Hyperplasia of Prostate

目的:探讨经尿道保留前列腺前叶等离子剜除术治疗前列腺增生症的临床疗效,为临床治疗提供理论依据。方法:选取符合标准的患者100例,采用随机数字的方法分为观察组和对照组各50例,观察组应用经尿道保留前列腺前叶等离子剜除术,对照组应用经尿道前列腺电切术,比较两组患者近期及远期临床疗效。结果:观察组患者手术时间、术中出血量、膀胱冲洗时间、导尿管留置时间及术后住院时间等指标,均显著低于对照组患者,差异有统计学意义(P<0.05)。观察组患者并发症发生率为10.00%,低于对照组患者的30.00%,差异有统计学意义(P<0.05)。随访6个月,两组患者国际前列腺症状评分(IPSS)、生活质量评分(QOL)、残余尿量(RUV)、最大尿流率(Qmax)较术前均明显改善,差异有统计学意义(P<0.05);术后6个月两组患者IPSS、Qmax、RUV及QOL相似,差异无统计学意义(P>0.05)。结论:经尿道保留前列腺前叶等离子剜除术治疗前列腺增生症的临床疗效与经尿道前列腺电切术相似,但术中出血量少、切除组织更完全、手术时间及术后住院时间短、患者恢复快等优点,值得推广应用。

Objective：To investigate the clinical therapeutic effects of transurethral plasmakinetic enu-cleation of the prostate （ anterior lobe of prostate reserved ） on hyperplasia of prostate , and to provide founda-tions for clinical treatment .Method：100 patients meeting the criteria were selected and randomly divided into observation group and control group , 50 patients in each group .The observation group was treated with transurethral plasmakinetic enucleation of the prostate （ anterior lobe of prostate reserved ） , while the control group treated with transurethral prostate electrocision , and the short-term and long-term clinical therapeutic effects were compared between the patients of the two groups .Result： The operative time , intra-operative blood loss , bladder washout time , time of urinary catheter in , and postoperative length of stay of the patients in the observation group were all significantly lower than those of the patients in the control group , and the differences were statistically significant （P＆lt;0.05）.The complication incidence of the patients in the observa-tion group was 10.00%, lower than that of the patients in the control group （30.00%）, and the difference was statistically significant （P＆lt;0.05）.All the patients were followed up for 6 months, the international pros-tate symptom scores （ IPSS） , scores of quality of life （ QOL） , residual urine volumes （ RUV） and maximum uroflow ratios （ Qmax） of the patients in both groups were significantly improved when compared with those before the operations, and the differences were statistically significant （P＆lt;0.05）;6 months after the opera-tions, the IPSS, Qmax, RUV and QOL of the two groups were similar , and the differences were statistically insignificant （ P＆gt;0.05） .Conclusion：Transurethral plasmakinetic enucleation of the prostate （ anterior lobe of prostate reserved ） has similar clinical therapeutic effects with transurethral prostate electrocision , but causes less intra-operative blood loss , cuts tissues more fully , needs shorter operative time and postoperative length of stay, renews the patients more rapidly , and consequently is worthy of application .